Historically, China’s chemical industry has mainly been located in coastal provinces, with Shandong as the biggest and Jiangsu as the second biggest province by chemical...
2021 was historic for chemical M&As, it was a record-breaking year in terms of total value of deals. Therefore, it was expected that 2022 would only build upon this...
Companies in the materials industry – including chemical companies – are seeing a revolution that is likely to drive a new wave of growth. To succeed, however, they will...
Sandoz, the generics and biosimilars arm of Swiss drugmaker Novartis, has signed a Memorandum of Understanding to build a biologics production plant in Lendava, Slovenia...
Ahead of a summit of EU leaders on Mar. 23-24, the European Commission has shaken out a cornucopia of proposals to stimulate green investment in the 27-member bloc.
Danish drugmaker Novo Nordisk has added its name to the list of insulin producers cutting prices for US retail buyers, following up on Eli Lilly’s announcement of price...
Bayer is looking to spend $1 billion on drug research and development in the United States during 2023 as part of a plan to double its sales in the country by the end of...
Private equity group Apollo has agreed to acquire Univar Solutions for $8.1 billion. The transaction also includes a “minority” investment from a wholly owned subsidiary...